鼻内镜下KTP激光辅助泪囊鼻腔造口术的临床疗效
Clinical outcome of endonasal KTP laser assisted dacryocystorhinostomy.
作者信息
Ressiniotis Thomas, Voros Gerasimos M, Kostakis Vasilios T, Carrie Sean, Neoh Christopher
机构信息
Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
出版信息
BMC Ophthalmol. 2005 Mar 3;5:2. doi: 10.1186/1471-2415-5-2.
BACKGROUND
To evaluate the clinical outcome of primary endonasal laser assisted dacryocystorhinostomy (ENL-DCR) using the potassium-titanyl-phosphate laser.
METHODS
We retrospectively reviewed all primary ENL-DCRs performed within a period of twelve months by the same combined Ophthalmology and Otorhinolaringology team in Freeman Hospital, Newcastle upon Tyne, UK. The main outcome measure for success was resolution or significant improvement of epiphora. Details of surgery, intraoperative and postoperative complications, as well as pathology associated with failure were also studied. Patients were followed up for at least 12 months.
RESULTS
A total of 41 consecutive ENL-DCRs on 29 patients (22 females, 7 males, mean age 75 years) were analysed. All patients had bicanalicular silicone intubation for at least 4 months. The success rate at 12 months postoperatively was 78.1%. Pathology associated with failure included: intranasal pathology (12.2%), mucocele (7.3%), and systemic sarcoidosis (2.4%). No significant intra-operative complications were recorded.
CONCLUSION
The ENL-DCR with potassium-titanyl-phosphate laser can be considered as a safe and efficient primary procedure for the treatment of nasolacrimal duct obstruction.
背景
评估使用磷酸钛氧钾激光进行原发性鼻内镜下激光辅助泪囊鼻腔造口术（ENL-DCR）的临床效果。
方法
我们回顾性分析了英国泰恩河畔纽卡斯尔弗里曼医院眼科和耳鼻咽喉科联合团队在十二个月内进行的所有原发性ENL-DCR手术。成功的主要评估指标是溢泪症状缓解或显著改善。还研究了手术细节、术中及术后并发症以及与手术失败相关的病理情况。对患者进行了至少12个月的随访。
结果
共分析了29例患者（22例女性，7例男性，平均年龄75岁）的41例连续ENL-DCR手术。所有患者均进行了双泪小管硅胶插管至少4个月。术后12个月的成功率为78.1%。与手术失败相关的病理情况包括：鼻内病变（12.2%）、黏液囊肿（7.3%）和系统性结节病（2.4%）。未记录到明显的术中并发症。
结论
磷酸钛氧钾激光ENL-DCR可被视为治疗鼻泪管阻塞的一种安全有效的原发性手术。
Zotero 插件